Acquisitions in Styria, Austria
Showing 4 transactions.
-
Headwall Group Acquires EVK DI Kerschhaggl GmbHJanuary 14, 2025
- Buyer
- Headwall Group, Arsenal Capital Partners
- Target
- EVK DI Kerschhaggl GmbH
- Industry
- Industrial Services
- Location
- Styria, Austria
- Type
- Addon
Headwall Group, a Bolton, Massachusetts-based portfolio company of Arsenal Capital Partners, has acquired Austria-based EVK DI Kerschhaggl GmbH (EVK), a developer of industrial sensor-based sorting and inspection systems. The acquisition expands Headwall's hyperspectral imaging and sensor capabilities to better serve markets such as food processing, plastics recycling, and material sorting.
-
Clubessential Holdings Acquires TAC (The Assistant Company)March 2, 2022
- Buyer
- Clubessential Holdings LLC
- Target
- TAC (The Assistant Company)
- Industry
- Cloud & SaaS
- Location
- Styria, Austria
- Type
- Addon
Clubessential Holdings acquired TAC (The Assistant Company), a Hartberg, Austria–based provider of spa, membership and access-control SaaS, expanding Clubessential's global footprint and adding spa and leisure capabilities. The deal increases Clubessential's international presence and customer reach in the spa, fitness and hospitality markets.
-
System Seals Acquires Plastoseal Produktions GmbHAugust 24, 2021
- Buyer
- System Seals Inc.
- Target
- Plastoseal Produktions GmbH
- Industry
- Manufacturing
- Location
- Styria, Austria
- Type
- Buyout
Cleveland-based System Seals Inc. has acquired Plastoseal Produktions GmbH, an Austrian manufacturer of engineered seals and plastic components, to expand its presence in Europe and broaden its GlobalOne supply-chain program. Plastoseal’s founder Wolfgang Kerschbaumer will remain as managing director as the companies integrate product ranges and R&D capabilities.
-
QPS Acquires JSW Life SciencesAugust 29, 2012
- Buyer
- QPS, LLC
- Target
- JSW Life Sciences GmbH
- Industry
- Healthcare Services
- Location
- Styria, Austria
- Type
- Buyout
QPS, LLC acquired a majority interest in JSW Life Sciences GmbH and will operate the business as QPS JSW. The deal expands QPS's preclinical capabilities (including CNS/transgenic models) and Phase II–IV clinical operations while strengthening its presence in Central and Eastern Europe.